NCT00368147

Brief Summary

The purpose of this study is to determine if the creation of a fistula or a graft plays a role in the development of heart disease for patients undergoing hemodialysis

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2002

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2002

Completed
4.4 years until next milestone

First Submitted

Initial submission to the registry

August 23, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 24, 2006

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2007

Completed
Last Updated

November 13, 2023

Status Verified

November 1, 2023

First QC Date

August 23, 2006

Last Update Submit

November 9, 2023

Conditions

Arteriovenous FistulaArteriovenous GraftLeft Ventricular HypertrophyBrain Natriuretic Peptide

Keywords

HemodialysisArteriovenous FistulaArteriovenous GraftLeft Ventricular HypertrophyBrain Natriuretic Peptide

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Heatlh Network

Toronto, Ontario, M5G 2C4, Canada

Location

MeSH Terms

Conditions

Arteriovenous FistulaHypertrophy, Left Ventricular

Condition Hierarchy (Ancestors)

Arteriovenous MalformationsVascular MalformationsCardiovascular AbnormalitiesCardiovascular DiseasesVascular FistulaVascular DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesFistulaPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsCardiomegalyHeart DiseasesHypertrophy

Study Officials

  • Deborah Zimmerman, MD

    Ottawa Hospital Research Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

August 23, 2006

First Posted

August 24, 2006

Study Start

April 1, 2002

Study Completion

February 1, 2007

Last Updated

November 13, 2023

Record last verified: 2023-11

Locations

CA(1)